{"id":23913,"date":"2013-11-22T12:51:17","date_gmt":"2013-11-22T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23913"},"modified":"2018-04-14T02:09:21","modified_gmt":"2018-04-14T07:09:21","slug":"23913","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/23913\/","title":{"rendered":"2013 \u5e74 11 \u6708 22 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_11-22-13.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n2013 \u5e74 11 \u6708 22 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<\/strong><br \/>\n\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n&nbsp;<br \/>\n\u7f16\u8f91\uff1aLynn Fondon DVM MBA<br \/>\n************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<br \/>\n&nbsp;<br \/>\n<u>Brakke \u54a8\u8be2\u65b0\u95fb<\/u><br \/>\n\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u62a5\u544a \u2013 <font color=\"#ff0000\">\u6700\u540e\u4e00\u6b21\u9884\u8ba2\u673a\u4f1a<br \/>\n<\/font>\u4ea4\u6613\u534f\u52a9<br \/>\n&nbsp;<br \/>\n<u>\u76c8\u5229\u65b0\u95fb<\/u><br \/>\nDS \u5236\u836f<br \/>\n\u65e5\u672c\u5584\u836f\u5de5\u4e1a\u516c\u53f8<br \/>\n\u5e15\u7279\u68ee<br \/>\n\u5149\u8c31\u54c1\u724c<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<\/u><br \/>\n\u5eb7\u6f58\u5236\u836f\u516c\u53f8<br \/>\n\u8868\u4f4d <br \/>\n\u683c\u6797\u514b\u7f57\u65af<br \/>\n\u7231\u5fb7\u58eb<br \/>\n\u514d\u75ab\u75ab\u82d7<br \/>\nKindred \u751f\u7269\u79d1\u5b66\u516c\u53f8 <br \/>\n\u731b\u72b8\u5ba0\u7269\u63a7\u80a1\u516c\u53f8<br \/>\n\u9ed8\u514b<br \/>\n\u83f2\u5e03\u7f57<br \/>\n\u97e6\u5766\u79d1<br \/>\nVireo \u7cfb\u7edf<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n12 \u6708\u5373\u5c06\u63a8\u51fa\uff1a<br \/>\n\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a<br \/>\n2013 \u5e74\u66f4\u65b0<br \/>\n<font color=\"#ff0000\">\u9884\u8ba2\u7684\u6700\u540e\u673a\u4f1a\uff01<\/font><\/strong><br \/>\n&nbsp;<br \/>\nBrakke Consulting \u5373\u5c06\u53d1\u5e03\u6211\u4eec 2013 \u5e74\u5173\u4e8e\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684\u62a5\u544a\u3002\u8be5\u62a5\u544a\u5305\u542b\u6709\u5173\u7f8e\u56fd\u5c0f\u52a8\u7269\u6740\u866b\u5242\u5e02\u573a\u7684\u5b9d\u8d35\u4fe1\u606f\uff0c\u5305\u62ec\uff1a<br \/>\n&nbsp;\u2013 \u9886\u5148\u7684\u517d\u533b\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u4ea7\u54c1\u7684\u4ea7\u54c1\u63cf\u8ff0\u3001\u4ef7\u683c\u548c\u9500\u552e<br \/>\n&nbsp;\u2013 \u517d\u533b\u548c\u975e\u5904\u65b9\u8df3\u86a4\u63a7\u5236\u5e02\u573a\u7684\u6982\u8ff0<br \/>\n&nbsp;\u2013 \u8ba8\u8bba\u975e\u4e13\u5229\u6c1f\u866b\u8148\u4ea7\u54c1\u7684\u5f71\u54cd<br \/>\n&nbsp;\u2013 2013 \u5e74\u5bf9 300 \u540d\u517d\u533b\u7684\u8c03\u67e5 <br \/>\n&nbsp;\u2013 2013 \u5e74\u5bf9 500 \u540d\u5ba0\u7269\u4e3b\u4eba\u7684\u8c03\u67e5<\/p>\n<p>\u5982\u679c\u5728 11 \u6708 26 \u65e5\u661f\u671f\u4e8c\u4e4b\u524d\u8ba2\u8d2d\uff0c\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u62a5\u544a\u7684\u8d2d\u4e70\u4ef7\u683c\u4e3a $6,995\uff0c\u5728\u8be5\u65e5\u671f\u4e4b\u540e\u8ba2\u8d2d\u7684\u4ef7\u683c\u4e3a $7,500\u3002<\/p>\n<p>\u8bf7\u8054\u7cfb Lynn Fondon \u535a\u58eb\uff0c\u7535\u8bdd\uff1a(972) 243-4033\uff0c\u6216 <a href=\"mailto:lfondon@brakkeconsulting.com\">lfondon@brakkeconsulting.com<\/a>&nbsp; \u9884\u8ba2\u62a5\u544a\uff0c\u6216\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n&nbsp;<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; Patterson Companies, Inc. \u516c\u5e03\u4e86\u622a\u81f3 2013 \u5e74 10 \u6708 26 \u65e5\u7684\u7b2c\u4e8c\u8d22\u5b63\u4e1a\u7ee9\u3002Patterson Veterinary \u90e8\u95e8\u7684\u9500\u552e\u989d\u8f83\u4e0a\u5e74\u540c\u671f\u589e\u957f 67%\uff0c\u8fbe\u5230 $3.08 \u4ebf\u7f8e\u5143\u3002\u8c03\u6574\u540e\uff0c\u5254\u9664\u6536\u8d2d\u82f1\u56fd NVS \u7684\u7efc\u5408\u9500\u552e\u989d\u8d21\u732e\uff0c\u7f8e\u56fd\u9500\u552e\u989d\u589e\u957f 3.3%\uff0c\u8fbe\u5230 $1.9 \u4ebf\u7f8e\u5143\u3002\uff08wsj.online.com\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u65e5\u672c\u5168\u836f\u5de5\u4e1a\u516c\u53f8\u62a5\u544a\u79f0\uff0c2013 \u8d22\u5e74\u4e0a\u534a\u5e74\uff082013 \u5e74 4 \u6708 1 \u65e5\u81f3 9 \u6708 30 \u65e5\uff09\u7684\u8425\u4e1a\u6536\u5165\u4e0e 2012 \u8d22\u5e74\u540c\u671f\u76f8\u6bd4\u589e\u957f\u4e86 2.7%\uff0c\u8fbe\u5230 121.3 \u4ebf\u65e5\u5143\uff08$1.23 \u4ebf\u65e5\u5143\uff09\u3002\uff08\u516c\u53f8\u901a\u8baf\uff09 <br \/>\n&nbsp;<br \/>\n&gt; DS Pharma \u52a8\u7269\u4fdd\u5065\u516c\u53f8\u516c\u5e03\u4e86\u622a\u81f3 2013 \u5e74 9 \u6708 30 \u65e5\u7684 2013 \u8d22\u5e74\u4e0a\u534a\u5e74\u4e1a\u7ee9\u3002\u4e0e\u53bb\u5e74\u4e0a\u534a\u5e74\u76f8\u6bd4\uff0c\u9500\u552e\u989d\u589e\u957f\u4e86 3.5%\uff0c\u8fbe\u5230 59 \u4ebf\u65e5\u5143\uff08$6000 \u4e07\u65e5\u5143\uff09\u3002\uff08\u516c\u53f8\u901a\u8baf\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Spectrum Brands Holdings, Inc. \u5ba3\u5e03\u4e86\u622a\u81f3 2013 \u5e74 9 \u6708 30 \u65e5\u7684 2013 \u8d22\u5e74\u4e1a\u7ee9\u3002\u672c\u8d22\u5e74\u7684\u5168\u7403\u5ba0\u7269\u7528\u54c1\u9500\u552e\u989d\u4e3a $6.22 \u4ebf\u7f8e\u5143\uff0c\u6bd4\u4e0a\u4e00\u8d22\u5e74\u589e\u957f\u4e86 1%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; \u582a\u8428\u65af\u5dde\u7acb\u5927\u5b66\u548c\u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5408\u4f5c\uff0c\u5728\u8be5\u6821\u4f4d\u4e8e\u582a\u8428\u65af\u5dde\u5965\u62c9\u897f\u7684\u6821\u56ed\u5185\u5f00\u8bbe\u4e86\u4e00\u4e2a\u65b0\u7684\u5fae\u751f\u7269\u76d1\u6d4b\u5b9e\u9a8c\u5ba4\u3002\u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u4e3a\u582a\u8428\u65af\u5dde\u5965\u62c9\u897f\u5206\u6821\u5fae\u751f\u7269\u76d1\u6d4b\u5b9e\u9a8c\u5ba4\u7684\u5efa\u8bbe\u63d0\u4f9b\u4e86\u6350\u8d60\u3002\u8be5\u5b9e\u9a8c\u5ba4\u5c06\u63d0\u4f9b\u8bca\u65ad\u652f\u6301\u670d\u52a1\uff0c\u6700\u521d\u5c06\u6ee1\u8db3\u9ed8\u514b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u7684\u72ec\u7279\u9700\u6c42\uff0c\u968f\u540e\u5c06\u6ee1\u8db3\u5176\u4ed6\u52a8\u7269\u4fdd\u5065\u884c\u4e1a\u5408\u4f5c\u4f19\u4f34\u7684\u9700\u6c42\u3002\uff08\u9972\u6599\uff09 <br \/>\n&nbsp;<br \/>\n&gt; IDEXX \u5b9e\u9a8c\u5ba4\u5ba3\u5e03\u63a8\u51fa SNAP Pro \u79fb\u52a8\u8bbe\u5907\uff0c\u8fd9\u662f\u4e00\u6b3e\u5148\u8fdb\u7684\u5373\u65f6\u8bca\u65ad\u4eea\u5668\uff0c\u53ef\u81ea\u52a8\u6fc0\u6d3b SNAP \u6d4b\u8bd5\u3001\u6355\u83b7\u548c\u4fdd\u5b58\u7ed3\u679c\u56fe\u50cf\u5e76\u5728\u60a3\u8005\u8bb0\u5f55\u4e2d\u8bb0\u5f55\u53d1\u7968\u8d39\u7528\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Phibro Animal Health Corporation \u548c Epitopix \u5df2\u8fbe\u6210\u5408\u4f5c\uff0c\u5c06\u57fa\u4e8e Epitopix \u7684\u65b0\u578b SRP \u6280\u672f\u5728\u7f8e\u56fd\u751f\u4ea7\u548c\u9500\u552e\u9e21\u7528\u751f\u7269\u5236\u54c1\u3002\u6b64\u5916\uff0c\u53cc\u65b9\u8fd8\u6253\u7b97\u5728\u5168\u7403\u8303\u56f4\u5185\u5f00\u5c55\u5408\u4f5c\uff0c\u5f00\u53d1\u57fa\u4e8e\u8be5\u6280\u672f\u7684\u72ec\u7279\u5bb6\u79bd\u751f\u7269\u5236\u54c1\u3002\uff08Digitaljournal.com\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; FDA \u62a5\u544a\u79f0\uff0cCompan Pharmaceuticals \u5df2\u83b7\u5f97\u5421\u7f57\u6614\u5eb7\u7528\u4e8e\u6cbb\u7597\u72ac\u8180\u80f1\u79fb\u884c\u7ec6\u80de\u764c\u7684\u6b21\u8981\u7528\u9014\u5c11\u6570\u7269\u79cd (MUMS) \u8ba4\u8bc1\u3002\uff08FDA\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Vireo Systems \u5ba3\u5e03\u63a8\u51fa CanineActiv\uff0c\u4e00\u79cd\u7528\u4e8e\u72d7\u7684 NSAID \u6b62\u75db\u836f\u66ff\u4ee3\u54c1\u3002\u8be5\u80f6\u56ca\u542b\u6709\u6297\u708e\u6210\u5206 Alpha-GEE\uff0c\u8fd9\u662f\u4e00\u79cd\u7531\u5929\u7136\u6c28\u57fa\u9178\u7ec4\u6210\u7684\u72ec\u7279\u5316\u5408\u7269\uff0c\u4ee5\u53ca\u4e00\u79cd\u7528\u4e8e\u72d7\u7684\u7279\u6b8a\u914d\u65b9\u987a\u52bf\u7597\u6cd5\u5316\u5408\u7269\u3002\uff08\u7f8e\u901a\u793e\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Immunovaccine Inc. \u62a5\u544a\u79f0\uff0c\u8be5\u516c\u53f8\u5df2\u5b8c\u6210\u6b64\u524d\u5ba3\u5e03\u7684\u8bc1\u5238\u79c1\u52df\uff0c\u52df\u96c6\u8d44\u91d1\u603b\u989d\u4e3a $4.2 \u767e\u4e07\u7f8e\u5143\u3002\u6839\u636e\u878d\u8d44\u6761\u6b3e\uff0cImmunovaccine \u5171\u8ba1\u51fa\u552e 10,511,209 \u80a1\u666e\u901a\u80a1\uff0c\u6bcf\u80a1\u4ef7\u683c\u4e3a $0.40 \u7f8e\u5143\u3002\uff08online.wsj.com\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Kindred Biosciences \u5ba3\u5e03\uff0c\u4eca\u5e74\u5c06\u901a\u8fc7\u7eb3\u65af\u8fbe\u514b\u9996\u6b21\u516c\u5f00\u52df\u80a1\u5bfb\u6c42 $5750 \u4e07\u7f8e\u5143\u7684\u878d\u8d44\u3002\u8be5\u516c\u53f8\u7684\u76ee\u6807\u662f\u5c06\u4eba\u7c7b\u5065\u5eb7\u836f\u7269\u5728\u4f34\u4fa3\u52a8\u7269\u9886\u57df\u63a8\u5411\u5546\u4e1a\u5316\u3002\u5176\u9996\u6b3e\u4ea7\u54c1 CereKin \u662f\u4e00\u79cd\u53e3\u670d\u7ec6\u80de\u56e0\u5b50\u6291\u5236\u5242\uff0c\u76ee\u524d\u6b63\u5728\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u7528\u4e8e\u6cbb\u7597\u72d7\u7684\u9aa8\u5173\u8282\u708e\u3002\uff08Animal Pharm\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u6fb3\u5927\u5229\u4e9a \u6fb3\u5927\u5229\u4e9a\u517d\u533b\u670d\u52a1\u516c\u53f8 Greencross \u5ba3\u5e03\u4e0e Mammoth Pet Holdings \u8fbe\u6210\u5408\u5e76\u534f\u8bae\uff0c\u540e\u8005\u5728\u6fb3\u5927\u5229\u4e9a\u7ecf\u8425 100 \u5bb6 Petbarn \u5ba0\u7269\u4e13\u5356\u5e97\uff0c\u5728\u65b0\u897f\u5170\u7ecf\u8425 24 \u5bb6 Animates \u5ba0\u7269\u4e13\u5356\u5e97\uff08\u540e\u8005\u901a\u8fc7\u4e0e EBOS Group \u6210\u7acb 50:50 \u5408\u8d44\u4f01\u4e1a\uff09\u3002\u5408\u5e76\u540e\uff0c2014 \u8d22\u5e74\u7684\u9884\u8ba1\u6536\u5165\u4e3a $4.43 \u4ebf\u3002\u4ee5\u80a1\u6362\u80a1\u8981\u7ea6\u5c06\u4f7f Greencross \u5411 Mammoth \u80a1\u4e1c\u53d1\u884c\u7ea6 5260 \u4e07\u80a1\u80a1\u7968\uff0c\u5360\u5408\u5e76\u540e\u516c\u53f8\u80a1\u4e1c\u540d\u518c\u7684 58.25%\u3002\uff08fool.com.au\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u963f\u6839\u5ef7 Vetanco \u5df2\u83b7\u5f97\u963f\u6839\u5ef7\u56fd\u5bb6\u536b\u751f\u548c\u98df\u54c1\u5b89\u5168\u5c40 SENASA \u6279\u51c6\uff0c\u53ef\u751f\u4ea7\u7528\u4e8e\u9884\u9632\u79bd\u7c7b\u6c99\u95e8\u6c0f\u83cc\u75c5\u7684\u65b0\u578b\u5bb6\u79bd\u75ab\u82d7\u3002\u8be5\u75ab\u82d7\u5c06\u5728\u56fd\u5185\u5e02\u573a\u548c\u51fa\u53e3\u5e02\u573a\u9500\u552e\u3002BiotechVac \u91c7\u7528\u91cd\u7ec4\u57fa\u56e0\u5de5\u7a0b\u6280\u672f\u8bbe\u8ba1\uff0c\u662f\u4e00\u79cd\u5b89\u5168\u7684\u53e3\u670d\u706d\u6d3b\u4e9a\u5355\u4f4d\u75ab\u82d7 - \u6297\u539f\u65e2\u4e0d\u662f\u51cf\u6bd2\u6d3b\u75ab\u82d7\uff0c\u4e5f\u4e0d\u662f\u6ce8\u5c04\u75ab\u82d7\u3002\u8be5\u75ab\u82d7\u901a\u8fc7\u6fc0\u6d3b\u7c98\u819c\u514d\u75ab\u7cfb\u7edf\u53d1\u6325\u4f5c\u7528\u3002\uff08Animal Pharm\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u03b2 \u53d7\u4f53\u6fc0\u52a8\u5242 \u7f8e\u56fd\u519c\u4e1a\u90e8\u5df2\u542f\u52a8\u4e00\u9879\u8ba4\u8bc1\u8ba1\u5212\uff0c\u5141\u8bb8\u751f\u4ea7\u7272\u755c\u3001\u725b\u8089\u548c\u732a\u8089\u4ea7\u54c1\u7684\u516c\u53f8\u4f7f\u7528\u201c\u4ece\u672a\u5582\u98df\u8fc7 \u03b2 \u53d7\u4f53\u6fc0\u52a8\u5242\u201d\u6807\u7b7e\u9500\u552e\u5176\u4ea7\u54c1\u3002\u7f8e\u56fd\u519c\u4e1a\u90e8\u519c\u4e1a\u8425\u9500\u670d\u52a1\u90e8\u8981\u6c42\u5bfb\u6c42\u53c2\u4e0e\u4ece\u672a\u5582\u98df\u8fc7 \u03b2 \u53d7\u4f53\u6fc0\u52a8\u5242\u8ba1\u5212\u7684\u516c\u53f8\u63d0\u4ea4\u7b26\u5408\u8be5\u673a\u6784\u7279\u5b9a\u6d41\u7a0b\u9a8c\u8bc1\u8ba1\u5212 (PVP) \u6216\u8d28\u91cf\u4f53\u7cfb\u8bc4\u4f30 (QSA) \u8ba1\u5212\u8981\u6c42\u7b49\u7684\u6587\u4ef6\u3002\uff08Vet Advantage\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 CVM \u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u7ba1\u7406\u5c40\u517d\u533b\u4e2d\u5fc3 (CVM) \u5ba3\u5e03\u89e3\u6563\u517d\u533b\u54a8\u8be2\u59d4\u5458\u4f1a (VMAC)\uff0c\u8be5\u59d4\u5458\u4f1a\u7531\u4e00\u7fa4\u5916\u90e8\u4e13\u5bb6\u7ec4\u6210\uff0c\u4ed6\u4eec\u4ee5\u653f\u5e9c\u7279\u6b8a\u96c7\u5458\u7684\u8eab\u4efd\u5c31\u52a8\u7269\u836f\u54c1\u548c\u98df\u54c1\u95ee\u9898\u63d0\u4f9b\u610f\u89c1\u3002CVM \u8868\u793a\uff0c\u5b83\u5c06\u5229\u7528\u5176\u4ed6\u8bba\u575b\u5c31\u76d1\u7ba1\u4e8b\u52a1\u5f81\u6c42\u4e13\u5bb6\u548c\u516c\u4f17\u610f\u89c1\u3002CVM \u8868\u793a\uff0c\u5b83\u8ba4\u4e3a VMAC \u5df2\u4e0d\u518d\u5fc5\u8981\uff0c\u56e0\u4e3a\u6709\u5176\u4ed6\u673a\u4f1a\u63d0\u4f9b\u610f\u89c1\uff1b\u4e0a\u4e00\u6b21 VMAC \u4f1a\u8bae\u662f\u5728 2010 \u5e74\uff0c\u8be5\u59d4\u5458\u4f1a\u5728\u8fc7\u53bb\u5341\u5e74\u4e2d\u53ea\u53ec\u5f00\u4e86\u516d\u6b21\u4f1a\u8bae\u3002\uff08\u9972\u6599\uff09<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n\u4ea4\u6613\u534f\u52a9 <br \/>\n\u65f6\u673a\u6210\u719f\u65f6<\/p>\n<p>\u60f3\u8981\u8d2d\u4e70\u3001\u51fa\u552e\u6216\u5408\u5e76\uff1f\u6211\u4eec\u53ef\u4ee5\u5e2e\u5fd9\uff01<\/p>\n<p>Brakke Consulting \u534f\u52a9\u8bb8\u591a\u5ba2\u6237\u8fdb\u884c\u5408\u5e76\u3001\u6536\u8d2d\u548c\u8d44\u4ea7\u5265\u79bb\u3002\u6211\u4eec\u7684\u4ea4\u6613\u4e13\u5bb6\u53ef\u4ee5\u63d0\u4f9b\u60a8\u5728\u52a8\u7269\u4fdd\u5065\u3001\u5ba0\u7269\u3001\u517d\u533b\u548c\u7279\u79cd\u5316\u5b66\u54c1\u5e02\u573a\u6240\u9700\u7684\u6d1e\u5bdf\u529b\u3001\u80fd\u529b\u548c\u8054\u7cfb\u3002\u8bf7\u8054\u7cfb\u6211\u4eec\u7684\u4efb\u4f55\u529e\u4e8b\u5904\u8fdb\u884c\u4fdd\u5bc6\u54a8\u8be2\u3002<\/p>\n<p><a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<\/p>\n<p>\u8fd9\u662f 2013 \u5e74\u5047\u671f\u5b63\u5373\u5c06\u5230\u6765\u4e4b\u524d\u7684\u6700\u540e\u4e00\u4efd\u7b80\u62a5\uff0c\u4e0b\u5468\u7f8e\u56fd\u5c06\u8fce\u6765\u611f\u6069\u8282\u3002\u6211\u4eec\u60f3\u501f\u6b64\u673a\u4f1a\u611f\u8c22\u6240\u6709\u5ba2\u6237\u5728 2013 \u5e74\u4e3a\u6211\u4eec\u63d0\u4f9b\u7684\u4e1a\u52a1\u3002\u6211\u4eec\u611f\u8c22\u4f60\u4eec\u6bcf\u4e00\u4e2a\u4eba\uff01\uff01 <br \/>\n&nbsp;<br \/>\n\u4eca\u5e74\u662f\u8be5\u884c\u4e1a\u53c8\u4e00\u4e2a\u79ef\u6781\u7684\u4e00\u5e74\uff0c\u6211\u4eec\u8ba4\u4e3a 2014 \u5e74\u53ef\u80fd\u4f1a\u5b9e\u73b0\u7c7b\u4f3c\u7684\u589e\u957f\u3002\u968f\u7740\u9972\u6599\u8c37\u7269\u4ef7\u683c\u4e0b\u964d\u548c\u7ecf\u6d4e\u590d\u82cf\uff0c2014 \u5e74\u5bf9\u98df\u7528\u52a8\u7269\u884c\u4e1a\u6765\u8bf4\u53ef\u80fd\u662f\u5f02\u5e38\u79ef\u6781\u7684\u4e00\u5e74\u3002\u4f34\u4fa3\u52a8\u7269\u4e2d\u4e00\u4e9b\u4e3b\u8981\u7c7b\u522b\u7684\u7ade\u4e89\u73af\u5883\u53ef\u80fd\u4f1a\u964d\u4f4e\u8be5\u9886\u57df\u7684\u589e\u957f\u6f5c\u529b\u3002<\/p>\n<p>\u795d\u60a8\u5ea6\u8fc7\u4e00\u4e2a\u6109\u5feb\u7684\u611f\u6069\u8282\u5047\u671f\uff0c\u5e76\u5403\u5927\u91cf\u7684\u52a8\u7269\u86cb\u767d\uff01<\/p>\n<p>\u7f57\u6069\u00b7\u5e03\u62c9\u514b<br \/>\n&nbsp;<br \/>\n**********************************<\/p>\n<p>\u672c\u7535\u5b50\u901a\u8baf\u5f52 Brakke Consulting, Inc. \u72ec\u6709\u3002<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf\u8fc7 Brakke Consulting, Inc. \u7684\u6279\u51c6\u5e76\u9002\u5f53\u6ce8\u660e\u6765\u6e90\u3002<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u548c\u8054\u5408\u7814\u7a76\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9 <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n12005 \u798f\u7279\u8def\uff0c530 \u5ba4<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c *************************************** Brakke Consulting 2013 \u5e74 11 \u6708 22 \u65e5\u7684\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u548c\u8bf4\u660e\u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. \u7f16\u8f91\uff1aLynn Fondon DVM MBA ************************************ \u65b0\u95fb\u62a5\u9053\uff1a Brakke Consulting \u65b0\u95fb \u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u4e0e\u5fc3\u4e1d\u866b\u5e02\u573a\u62a5\u544a - \u6700\u540e\u9884\u8ba2\u673a\u4f1a \u4ea4\u6613\u534f\u52a9\u6536\u76ca\u65b0\u95fb DS Pharma Nippon Zenyaku Kogyo Patterson Spectrum Brands \u5176\u4ed6\u65b0\u95fb Compan Pharmaceuticals Epitopix Greencross IDEXX Immunovaccine Kindred Biosciences Mammoth Pet Holdings Merck Phibro Vetanco Vireo Systems *********************************** BRAKKE CONSULTING, INC. 12 \u6708\u5373\u5c06\u63a8\u51fa\uff1a\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u4e0e\u5fc3\u4e1d\u866b\u5e02\u573a 2013 \u5e74\u66f4\u65b0 \u6700\u540e\u9884\u8ba2\u673a\u4f1a\uff01 Brakke Consulting \u5373\u5c06\u53d1\u5e03\u6211\u4eec 2013 \u5e74\u5173\u4e8e\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684\u62a5\u544a\u3002\u8be5\u62a5\u544a\u5305\u542b\u6709\u5173\u7f8e\u56fd\u5c0f\u52a8\u7269\u6740\u866b\u5242\u5e02\u573a\u7684\u5b9d\u8d35\u4fe1\u606f\uff0c\u5305\u62ec\uff1a \u2013 \u9886\u5148\u7684\u517d\u533b\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u4ea7\u54c1\u7684\u4ea7\u54c1\u63cf\u8ff0\u3001\u4ef7\u683c\u548c\u9500\u552e \u2013 \u517d\u533b\u548c\u975e\u5904\u65b9\u8df3\u86a4\u63a7\u5236\u5e02\u573a\u6982\u8ff0 \u2013 \u901a\u7528\u6c1f\u866b\u8148\u4ea7\u54c1\u5f71\u54cd\u7684\u8ba8\u8bba \u2013 2013 \u5e74\u5bf9 300 \u540d\u517d\u533b\u7684\u8c03\u67e5 \u2013 2013 \u5e74\u5bf9 500 \u540d\u5ba0\u7269\u4e3b\u4eba\u7684\u8c03\u67e5 \u5982\u679c\u5728 11 \u6708 26 \u65e5\u661f\u671f\u4e8c\u4e4b\u524d\u8ba2\u8d2d\uff0c\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684\u62a5\u544a\u5c06\u4ee5 $6,995 \u7684\u4ef7\u683c\u51fa\u552e\uff0c\u5728\u8be5\u65e5\u671f\u4e4b\u540e\u5219\u4e3a $7,500\u3002\u8bf7\u8054\u7cfb Lynn Fondon \u535a\u58eb\uff0c\u7535\u8bdd (972) 243-4033 \u6216 lfondon@brakkeconsulting.com \u9884\u8ba2\u62a5\u544a\uff0c<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23913\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23913","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/23913\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 22, 2013 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news US Flea Control &amp; Heartworm Markets report &#8211; last chance to pre-order Transaction assistance &nbsp; earnings news DS Pharma Nippon Zenyaku Kogyo Patterson Spectrum Brands &nbsp; other news Compan Pharmaceuticals Epitopix Greencross IDEXX Immunovaccine Kindred Biosciences Mammoth Pet Holdings Merck Phibro Vetanco Vireo Systems &nbsp; ************************************ BRAKKE CONSULTING, INC. COMING IN DECEMBER: US FLEA CONTROL &amp; HEARTWORM MARKETS 2013 UPDATE LAST CHANCE TO PRE-ORDER! &nbsp; Brakke Consulting will soon be publishing our 2013 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: &nbsp;&#8211; Product descriptions, prices, and sales for the leading veterinary flea and heartworm products &nbsp;&#8211; an overview of the veterinary and OTC flea control markets &nbsp;&#8211; discussion of the impact of generic fipronil products &nbsp;&#8211; 2013 survey of 300 veterinarians &nbsp;&#8211; 2013 survey of 500 pet owners The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $6,995 if ordered by TUESDAY, NOVEMBER 26, and $7,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com&nbsp; to pre-order the report,View Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/23913\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2013-11-22T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:09:21+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for November 22, 2013\",\"datePublished\":\"2013-11-22T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/\"},\"wordCount\":1325,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/\",\"url\":\"https:\/\/brakkeconsulting.com\/23913\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2013-11-22T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:09:21+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/23913\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/23913\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for November 22, 2013\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/23913\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 22, 2013 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news US Flea Control &amp; Heartworm Markets report &#8211; last chance to pre-order Transaction assistance &nbsp; earnings news DS Pharma Nippon Zenyaku Kogyo Patterson Spectrum Brands &nbsp; other news Compan Pharmaceuticals Epitopix Greencross IDEXX Immunovaccine Kindred Biosciences Mammoth Pet Holdings Merck Phibro Vetanco Vireo Systems &nbsp; ************************************ BRAKKE CONSULTING, INC. COMING IN DECEMBER: US FLEA CONTROL &amp; HEARTWORM MARKETS 2013 UPDATE LAST CHANCE TO PRE-ORDER! &nbsp; Brakke Consulting will soon be publishing our 2013 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: &nbsp;&#8211; Product descriptions, prices, and sales for the leading veterinary flea and heartworm products &nbsp;&#8211; an overview of the veterinary and OTC flea control markets &nbsp;&#8211; discussion of the impact of generic fipronil products &nbsp;&#8211; 2013 survey of 300 veterinarians &nbsp;&#8211; 2013 survey of 500 pet owners The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $6,995 if ordered by TUESDAY, NOVEMBER 26, and $7,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com&nbsp; to pre-order the report,View Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/23913\/","og_site_name":"Brakke Consulting Website","article_published_time":"2013-11-22T18:51:17+00:00","article_modified_time":"2018-04-14T07:09:21+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"7 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/23913\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/23913\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for November 22, 2013","datePublished":"2013-11-22T18:51:17+00:00","dateModified":"2018-04-14T07:09:21+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/23913\/"},"wordCount":1325,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/23913\/","url":"https:\/\/brakkeconsulting.com\/23913\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2013-11-22T18:51:17+00:00","dateModified":"2018-04-14T07:09:21+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/23913\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/23913\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/23913\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for November 22, 2013"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=23913"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23913\/revisions"}],"predecessor-version":[{"id":25413,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23913\/revisions\/25413"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=23913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=23913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=23913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}